<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27</volume><submitter>Scheurer F</submitter><pubmed_abstract>Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) are an important resource for identifying novel therapeutic targets and cardioprotective drugs. However, a key limitation of iPSC-CMs is their immature, fetal-like phenotype. Cultivation of iPSC-CMs in lipid-supplemented maturation media (MM) enhances the structural, metabolic and electrophysiological properties of iPSC-CMs. Nevertheless, they face substantial limitations as there are labor-intensive, time consuming and go in line with cell damage or loss of the sample. To address this issue, we have developed a non-invasive approach for automated classification of iPSC-CM maturity through interpretable artificial intelligence (AI)-based analysis of beat characteristics derived from video-based motion analysis. In a pros</pubmed_abstract><journal>Computational and structural biotechnology journal</journal><pagination>3719-3728</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12409467</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Non-invasive maturity assessment of iPSC-CMs based on optical maturity characteristics using interpretable AI.</pubmed_title><pmcid>PMC12409467</pmcid><pubmed_authors>Guan K</pubmed_authors><pubmed_authors>Sonntag F</pubmed_authors><pubmed_authors>Schmidt M</pubmed_authors><pubmed_authors>Schubert M</pubmed_authors><pubmed_authors>Hammer A</pubmed_authors><pubmed_authors>Steiner RP</pubmed_authors><pubmed_authors>Gamm O</pubmed_authors><pubmed_authors>Scheurer F</pubmed_authors><pubmed_authors>Malberg H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-invasive maturity assessment of iPSC-CMs based on optical maturity characteristics using interpretable AI.</name><description>Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) are an important resource for identifying novel therapeutic targets and cardioprotective drugs. However, a key limitation of iPSC-CMs is their immature, fetal-like phenotype. Cultivation of iPSC-CMs in lipid-supplemented maturation media (MM) enhances the structural, metabolic and electrophysiological properties of iPSC-CMs. Nevertheless, they face substantial limitations as there are labor-intensive, time consuming and go in line with cell damage or loss of the sample. To address this issue, we have developed a non-invasive approach for automated classification of iPSC-CM maturity through interpretable artificial intelligence (AI)-based analysis of beat characteristics derived from video-based motion analysis. In a pros</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-03T07:06:18.635Z</modification><creation>2026-05-29T03:05:29.96Z</creation></dates><accession>S-EPMC12409467</accession><cross_references><pubmed>40917985</pubmed><doi>10.1016/j.csbj.2025.08.024</doi></cross_references></HashMap>